Technical Analysis for ALZN - Alzamend Neuro, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 4.78% | |
Narrow Range Bar | Range Contraction | 4.78% | |
Lower Bollinger Band Walk | Weakness | 4.78% | |
Stochastic Reached Oversold | Weakness | 4.78% | |
BB Squeeze + Lower Band Touch | Range Contraction | 4.78% | |
Lower Bollinger Band Touch | Weakness | 4.78% | |
Oversold Stochastic | Weakness | 4.78% | |
Bollinger Band Squeeze | Range Contraction | 5.45% |
Alert | Time |
---|---|
Rose Above 20 DMA | about 17 hours ago |
Rose Above 10 DMA | about 17 hours ago |
Up 5% | about 17 hours ago |
20 DMA Resistance | about 18 hours ago |
10 DMA Resistance | about 18 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/11/2024
Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication Neuroscience Alzheimer's Disease Neurodegenerative Diseases Dementia Psychiatric Diagnosis Amyloidosis Neurodegeneration Preclinical Stage Biopharmaceutical Psychiatric Disorders Treatment Of Neurodegenerative Diseases Treatment Of Alzheimer's
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Biology Medication Neuroscience Alzheimer's Disease Neurodegenerative Diseases Dementia Psychiatric Diagnosis Amyloidosis Neurodegeneration Preclinical Stage Biopharmaceutical Psychiatric Disorders Treatment Of Neurodegenerative Diseases Treatment Of Alzheimer's
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 20.0 |
52 Week Low | 1.4 |
Average Volume | 363,844 |
200-Day Moving Average | 5.46 |
50-Day Moving Average | 1.85 |
20-Day Moving Average | 1.63 |
10-Day Moving Average | 1.63 |
Average True Range | 0.15 |
RSI (14) | 45.65 |
ADX | 19.48 |
+DI | 26.70 |
-DI | 19.49 |
Chandelier Exit (Long, 3 ATRs) | 1.44 |
Chandelier Exit (Short, 3 ATRs) | 1.93 |
Upper Bollinger Bands | 1.73 |
Lower Bollinger Band | 1.53 |
Percent B (%b) | 0.58 |
BandWidth | 11.81 |
MACD Line | -0.08 |
MACD Signal Line | -0.10 |
MACD Histogram | 0.0206 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.80 | ||||
Resistance 3 (R3) | 1.79 | 1.72 | 1.78 | ||
Resistance 2 (R2) | 1.72 | 1.68 | 1.73 | 1.77 | |
Resistance 1 (R1) | 1.68 | 1.66 | 1.70 | 1.70 | 1.76 |
Pivot Point | 1.62 | 1.62 | 1.63 | 1.62 | 1.62 |
Support 1 (S1) | 1.58 | 1.58 | 1.60 | 1.59 | 1.53 |
Support 2 (S2) | 1.51 | 1.55 | 1.52 | 1.52 | |
Support 3 (S3) | 1.47 | 1.51 | 1.51 | ||
Support 4 (S4) | 1.49 |